Cargando…
Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration
Loss of skin integrity can lead to serious problems and even death. In this study, for the first time, the effect of exopolysaccharide (EPS) produced by cold-adapted yeast R. mucilaginosa sp. GUMS16 on a full-thickness wound in rats was evaluated. The GUMS16 strain’s EPS was precipitated by adding c...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000589/ https://www.ncbi.nlm.nih.gov/pubmed/33802198 http://dx.doi.org/10.3390/polym13060854 |
_version_ | 1783671032457986048 |
---|---|
author | Hivechi, Ahmad Milan, Peiman Brouki Modabberi, Khashayar Amoupour, Moein Ebrahimzadeh, Kaveh Gholipour, Amir Reza Sedighi, Faezeh Amini, Naser Bahrami, S. Hajir Rezapour, Alireza Hamidi, Masoud Delattre, Cédric |
author_facet | Hivechi, Ahmad Milan, Peiman Brouki Modabberi, Khashayar Amoupour, Moein Ebrahimzadeh, Kaveh Gholipour, Amir Reza Sedighi, Faezeh Amini, Naser Bahrami, S. Hajir Rezapour, Alireza Hamidi, Masoud Delattre, Cédric |
author_sort | Hivechi, Ahmad |
collection | PubMed |
description | Loss of skin integrity can lead to serious problems and even death. In this study, for the first time, the effect of exopolysaccharide (EPS) produced by cold-adapted yeast R. mucilaginosa sp. GUMS16 on a full-thickness wound in rats was evaluated. The GUMS16 strain’s EPS was precipitated by adding cold ethanol and then lyophilized. Afterward, the EPS with polycaprolactone (PCL) and gelatin was fabricated into nanofibers with two single-needle and double-needle procedures. The rats’ full-thickness wounds were treated with nanofibers and Hematoxylin and eosin (H&E) and Masson’s Trichrome staining was done for studying the wound healing in rats. Obtained results from SEM, DLS, FTIR, and TGA showed that EPS has a carbohydrate chemical structure with an average diameter of 40 nm. Cell viability assessments showed that the 2% EPS loaded sample exhibits the highest cell activity. Moreover, in vivo implantation of nanofiber webs on the full-thickness wound on rat models displayed a faster healing rate when EPS was loaded into a nanofiber. These results suggest that the produced EPS can be used for skin tissue engineering applications. |
format | Online Article Text |
id | pubmed-8000589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80005892021-03-28 Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration Hivechi, Ahmad Milan, Peiman Brouki Modabberi, Khashayar Amoupour, Moein Ebrahimzadeh, Kaveh Gholipour, Amir Reza Sedighi, Faezeh Amini, Naser Bahrami, S. Hajir Rezapour, Alireza Hamidi, Masoud Delattre, Cédric Polymers (Basel) Article Loss of skin integrity can lead to serious problems and even death. In this study, for the first time, the effect of exopolysaccharide (EPS) produced by cold-adapted yeast R. mucilaginosa sp. GUMS16 on a full-thickness wound in rats was evaluated. The GUMS16 strain’s EPS was precipitated by adding cold ethanol and then lyophilized. Afterward, the EPS with polycaprolactone (PCL) and gelatin was fabricated into nanofibers with two single-needle and double-needle procedures. The rats’ full-thickness wounds were treated with nanofibers and Hematoxylin and eosin (H&E) and Masson’s Trichrome staining was done for studying the wound healing in rats. Obtained results from SEM, DLS, FTIR, and TGA showed that EPS has a carbohydrate chemical structure with an average diameter of 40 nm. Cell viability assessments showed that the 2% EPS loaded sample exhibits the highest cell activity. Moreover, in vivo implantation of nanofiber webs on the full-thickness wound on rat models displayed a faster healing rate when EPS was loaded into a nanofiber. These results suggest that the produced EPS can be used for skin tissue engineering applications. MDPI 2021-03-10 /pmc/articles/PMC8000589/ /pubmed/33802198 http://dx.doi.org/10.3390/polym13060854 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hivechi, Ahmad Milan, Peiman Brouki Modabberi, Khashayar Amoupour, Moein Ebrahimzadeh, Kaveh Gholipour, Amir Reza Sedighi, Faezeh Amini, Naser Bahrami, S. Hajir Rezapour, Alireza Hamidi, Masoud Delattre, Cédric Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration |
title | Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration |
title_full | Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration |
title_fullStr | Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration |
title_full_unstemmed | Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration |
title_short | Synthesis and Characterization of Exopolysaccharide Encapsulated PCL/Gelatin Skin Substitute for Full-Thickness Wound Regeneration |
title_sort | synthesis and characterization of exopolysaccharide encapsulated pcl/gelatin skin substitute for full-thickness wound regeneration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000589/ https://www.ncbi.nlm.nih.gov/pubmed/33802198 http://dx.doi.org/10.3390/polym13060854 |
work_keys_str_mv | AT hivechiahmad synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT milanpeimanbrouki synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT modabberikhashayar synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT amoupourmoein synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT ebrahimzadehkaveh synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT gholipouramirreza synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT sedighifaezeh synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT amininaser synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT bahramishajir synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT rezapouralireza synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT hamidimasoud synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration AT delattrecedric synthesisandcharacterizationofexopolysaccharideencapsulatedpclgelatinskinsubstituteforfullthicknesswoundregeneration |